Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 107086
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.107086
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.107086
Figure 7 Summary of the treatment course.
SCC: Squamous cell carcinoma; DCF: Docetaxel, cisplatin, and 5-fluorouracil; NEC: Neuroendocrine carcinoma; MiNEN: Mixed neuroendocrine non-neuroendocrine neoplasm; IP: Irinotecan + cisplatin.
- Citation: Okamoto K, Fujisawa K, Kono K, Ogawa Y, Shimoyama H, Haruta S, Takazawa Y, Ueno M, Udagawa H. Long-term survival with multimodal treatment including conversion surgery for locally advanced esophageal neuroendocrine carcinoma: A case report. World J Gastrointest Surg 2025; 17(6): 107086
- URL: https://www.wjgnet.com/1948-9366/full/v17/i6/107086.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i6.107086